Clinical Trial Update: WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) Subjects

View source ↗

Summary

The GlaxoSmithKline-sponsored clinical trial WEUSKOP6416 evaluating pneumonia in chronic obstructive pulmonary disease subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pneumonia

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED